Replies to post #383647 on Amarin Corp Plc (AMRN)

[dogn]

Denner used DCF modeling to conclude AMRN was significantly undervalued when establishing Sarissa Capital's ~6% stake, with cost basis ~$4.46
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167621357

Apart from possible hedging profits, they're down ~71% at today's $1.29 close.

I trust they have confidence in their numbers to invest $107M and hold while current stake valuation now ~$31M. Would like to know their calculated true value estimate.

Your $3B~$7.56/share.

Some other DCF valuations, FWIW:
https://www.alphaspread.com/security/nasdaq/amrn/dcf-valuation/base-case
Base Case $3.29 per share ($1.31B market cap; undervalued by 59%)
https://www.alphaspread.com/security/nasdaq/amrn/dcf-valuation/bull-case
Bull Case $12.26 per share ($4.87B market cap; undervalued by 89%)

https://www.macroaxis.com/valuation/AMRN/Amarin-Corp-ADR
"Prevailing Real Value" of $3.45 per share ($1.37B market cap; undervalued by 63%); Estimated Upside to $11.81 ($4.69B market cap; undervalued by 89%)

https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amrn/amarin
"Trading at 88.6% below our estimate of its fair value" (based on yesterday's $1.35 close), implies $11.84 per share fair value ($4.7B market cap)

Current average analyst 12 month target price $3.57 ($1.42B market cap).
https://www.marketwatch.com/investing/stock/amrn/analystestimates?mod=mw_quote_tab

Greater certainty with projections will come with MITIGATE & RESPECT-EPA results, additional country approvals/reimbursement data, combo pill, with wildcards like BRAVE Alzheimers trial. Going to be a long slog, but I'm optimistic for long term investment success. Latest MO noise completely disregards JELIS/CHERRY/EVAPORATE non-MO placebo trial successes, clear anti-inflammatory action of EPA, that biomarker changes were small on absolute level, etc. Sure seems AF/MH STAT team has an agenda to so persistently attack. Very one-sided story IMO. Would like to see their conflict of interest disclosures.
dogn